Home > Insider Trading > Filing (0000904454-13-000859)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1274644	Ocera Therapeutics Inc.	OCRX	Pharmaceutical Preparations (2834)	631192270

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1013425	I Jesse Treu	C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-07-15	988,285	$6.03	988,285	No	4	P	Indirect	By Domain Partners VIII, L.P.
Common Stock	Acquisiton	2013-07-15	7,333	$6.03	7,333	No	4	P	Indirect	By DP VIII Associates, L.P.
Common Stock	Acquisiton	2013-07-15	331,873	$6.03	1,857,036	No	4	P	Indirect	By Domain Partners VI, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Domain Partners VIII, L.P.
No	4	P	Indirect	By DP VIII Associates, L.P.
No	4	P	Indirect	By Domain Partners VI, L.P.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	15,731	Indirect	By DP VI Associates, L.P.
Common Stock	47,963	Indirect	By Domain Associates, LLC

Footnotes

The Reporting Person is a Managing Member of (i) One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P., (ii) One Palmer Square Associates VI, LLC, which is the sole general partner of Domain Partners VI, L.P. and DP VI Associates, L.P., and (iii) Domain Associates, LLC. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.